Učitavanje...
Germlining of the HIV-1 broadly neutralizing antibody domain m36
Engineered antibody domains (eAds) have emerged as a novel class of HIV-1 inhibitors and are currently under preclinical testing as promising drug candidates for prevention and therapy of HIV-1 infection. Reverse mutation of antibodies to germline sequences (germlining) could not only identify less...
Spremljeno u:
| Izdano u: | Antiviral Res |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4357557/ https://ncbi.nlm.nih.gov/pubmed/25676867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.02.001 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|